Latest News and Events
Filter by
Selections
April 11, 2018
Arrowhead Pharmaceuticals Presents ARC-520 Clinical Data at The International Liver Congress™
Read MoreMarch 28, 2018
Arrowhead Pharmaceuticals Announces Multiple Presentations at The International Liver Congress™
Read MoreMarch 27, 2018
Arrowhead Begins Dosing in Phase 1/2 Study of ARO-HBV for Treatment of Chronic Hepatitis B
Read MoreMarch 20, 2018
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)
Read MoreMarch 12, 2018
Arrowhead Begins Dosing in Phase 1 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease
Read MoreFebruary 22, 2018